| Product |
CAS |
Molecular formula |
More |
| 3-Methyl-n-(pyrrolidin-3-yl)pyrazin-2-amine hydrochloride |
1420808-58-7 |
C9H15ClN4 |
More |
| 3-Methyl-n-(pyrrolidin-2-ylmethyl)pyrazin-2-amine hydrochloride |
1420961-56-3 |
C10H17ClN4 |
More |
| 3-Methyl-n-(pyrrolidin-3-ylmethyl)pyrazin-2-amine hydrochloride |
1420961-66-5 |
C10H17ClN4 |
More |
| 1-(3-Methylpyrazin-2-yl)pyrrolidin-3-amine hydrochloride |
1420887-14-4 |
C9H15ClN4 |
More |
| (1-(3-Methylpyrazin-2-yl)pyrrolidin-2-yl)methanamine hydrochloride |
1420894-73-0 |
C10H17ClN4 |
More |
| (1-(3-Methylpyrazin-2-yl)pyrrolidin-3-yl)methanamine hydrochloride |
1420961-75-6 |
C10H17ClN4 |
More |
| 2-Methyl-3-(piperazin-1-yl)pyrazine hydrochloride |
1420878-06-3 |
C9H15ClN4 |
More |
| 2-Methyl-3-(3-methylpiperazin-1-yl)pyrazine hydrochloride |
1420958-17-3 |
C10H17ClN4 |
More |
| 2-Methyl-3-(2-methylpiperazin-1-yl)pyrazine hydrochloride |
1420887-58-6 |
C10H17ClN4 |
More |
| (3-(Methylamino)piperidin-1-yl)(pyrazin-2-yl)methanone hydrochloride |
1420787-33-2 |
C11H17ClN4O |
More |
| (4-(Methylamino)piperidin-1-yl)(pyrazin-2-yl)methanone hydrochloride |
1420887-82-6 |
C11H17ClN4O |
More |
| (3-Methylpiperazin-1-yl)(pyrazin-2-yl)methanone hydrochloride |
1420882-41-2 |
C10H15ClN4O |
More |
| (2-Methylpiperazin-1-yl)(pyrazin-2-yl)methanone hydrochloride |
1420887-93-9 |
C10H15ClN4O |
More |
| 2-(3-Methylpiperazin-1-yl)pyrazine hydrochloride |
1420992-73-9 |
C9H15ClN4 |
More |
| 2-(2-Methylpiperazin-1-yl)pyrazine hydrochloride |
1420988-71-1 |
C9H15ClN4 |
More |
| 2-((3-Methylpiperazin-1-yl)methyl)pyrazine hydrochloride |
1420956-03-1 |
C10H17ClN4 |
More |
| 2-((2-Methylpiperazin-1-yl)methyl)pyrazine hydrochloride |
1420853-59-3 |
C10H17ClN4 |
More |
| 2-(Methyl(piperidin-3-yl)amino)-1-(pyrazin-2-yl)ethanone hydrochloride |
1420888-44-3 |
C12H19ClN4O |
More |
| 2-(Methyl(piperidin-4-yl)amino)-1-(pyrazin-2-yl)ethanone hydrochloride |
1420787-99-0 |
C12H19ClN4O |
More |
| 2-(Methyl(piperidin-2-ylmethyl)amino)-1-(pyrazin-2-yl)ethanone hydroch |
1420972-74-2 |
C13H21ClN4O |
More |